CCL3 and COVID-19: The findings showed that compared to healthy controls, patients with COVID-19 had significantly higher levels of interleukins 1α, 2, 6, 7, 8, 10 and 15, CRP, SAA, ICAM-1, VCAM-1, CXCL10, CCL3, CCL26, IFN-γ, TNF-α, bFGF, PlGF, and Flt-1.